Stock Chart

HCM

$14.27 -2.06%
Score: 39.6 AVOID NEW MONEY
Pro
Screener
Vol: 0.19x (vs SPY: 0.7x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 01, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About HCM - HUTCHMED (China) Limited American Depositary Shares

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Key Statistics

Market Cap $3B
P/E Ratio 146.30

This HCM stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track HCM's price movements with trendlines, gamma walls, and key support/resistance levels.